These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10444318)

  • 41. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
    Khan WA; Seas C; Dhar U; Salam MA; Bennish ML
    Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
    Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
    Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
    Fernandez LA
    J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of health services utilization on the recovery from dysentery.
    Myaux JA; Chakraborty J; Yunus M; Khan EH; de Francisco A
    J Trop Pediatr; 1996 Feb; 42(1):38-42. PubMed ID: 8820619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotics for the treatment of dysentery in children.
    Traa BS; Walker CL; Munos M; Black RE
    Int J Epidemiol; 2010 Apr; 39 Suppl 1(Suppl 1):i70-4. PubMed ID: 20348130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [TREATMENT OF BACILLARY DYSEMTERY WITH NALIDIXIC ACID].
    NAKAMIZO Y; TAKAHASHI R; TANAKA E
    Nihon Densenbyo Gakkai Zasshi; 1963 Oct; 37():241-7. PubMed ID: 14092815
    [No Abstract]   [Full Text] [Related]  

  • 49. An evaluation of current shigellosis treatment.
    Bhattacharya SK; Sur D
    Expert Opin Pharmacother; 2003 Aug; 4(8):1315-20. PubMed ID: 12877639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial.
    Bennish ML; Salam MA; Khan WA; Khan AM
    Ann Intern Med; 1992 Nov; 117(9):727-34. PubMed ID: 1416574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
    Salam MA; Bennish ML
    J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
    Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
    J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidrug resistant epidemic shigellosis in a village in west Bengal, 1984.
    Sengupta PG; Mandal S; Sen D; Das P; Deb BC; Pal SC
    Indian J Public Health; 1990; 34(1):15-9. PubMed ID: 2101383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial susceptibilities of Shigella dysenteriae type 1 isolated in Zimbabwe--implications for the management of dysentery.
    Mason PR; Nathoo KJ; Wellington M; Mason E
    Cent Afr J Med; 1995 Apr; 41(4):132-7. PubMed ID: 7788685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current perspectives of enteric fever: a hospital-based study from India.
    Walia M; Gaind R; Mehta R; Paul P; Aggarwal P; Kalaivani M
    Ann Trop Paediatr; 2005 Sep; 25(3):161-74. PubMed ID: 16156980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention.
    Ries AA; Wells JG; Olivola D; Ntakibirora M; Nyandwi S; Ntibakivayo M; Ivey CB; Greene KD; Tenover FC; Wahlquist SP
    J Infect Dis; 1994 May; 169(5):1035-41. PubMed ID: 8169388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Shigella dysenteriae serotype 1, Kolkata, India.
    Dutta S; Dutta S; Dutta P; Matsushita S; Bhattacharya SK; Yoshida S
    Emerg Infect Dis; 2003 Nov; 9(11):1471-4. PubMed ID: 14718096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.